CoChat
Sign Up
Cited by 65

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells

Han, Shin, Dae Hwan, Kim, Jung Seok, Weon, Kwon Yeon, Jang, Chang-Young, Kim, Jin-Seok·2016·International Journal of Nanomedicine
DOI 10.2147/ijn.s95850PMC PMC4827594
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/ijn.s95850

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 3 references

Research works printed but not linked: 54

  1. [1]Siegel R Ma J Zou Z Jemal A Cancer statistics, 2014 CA Cancer J Clin 2014 64 1 9 29 24399786
  2. [2]Warner E Clinical practice. Breast-cancer screening N Engl J Med 2011 365 11 1025 1032 21916640
  3. [3]Vo AT Millis RM Epigenetics and breast cancers Obstet Gynecol Int 2012 2012 602720 22567014 PMC3337495
  4. [5]Al-Hajj M Wicha MS Benito-Hernandez A Morrison SJ Clarke MF Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci U S A 2003 100 7 3983 3988 12629218 PMC153034
  5. [6]Singh SK Clarke ID Terasaki M Identification of a cancer stem cell in human brain tumors Cancer Res 2003 63 18 5821 5828 14522905
  6. [7]O’Brien CA Pollett A Gallinger S Dick JE A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 2007 445 7123 106 110 17122772
  7. [8]Matsui W Huff CA Wang Q Characterization of clonogenic multiple myeloma cells Blood 2004 103 6 2332 2336 14630803 PMC3311914
  8. [9]Li C Heidt DG Dalerba P Identification of pancreatic cancer stem cells Cancer Res 2007 67 3 1030 1037 17283135
  9. [10]Lagasse E Weissman IL Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice Cell 1997 89 7 1021 1031 9215625
  10. [11]Lagasse E Weissman IL bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages J Exp Med 1994 179 3 1047 1052 8113673 PMC2191411
  11. [12]Domen J Gandy KL Weissman IL Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation Blood 1998 91 7 2272 2282 9516125
  12. [14]Turley EA Noble PW Bourguignon LY Signaling properties of hyaluronan receptors J Biol Chem 2002 277 7 4589 4592 11717317
  13. [15]Aruffo A Stamenkovic I Melnick M Underhill CB Seed B CD44 is the principal cell surface receptor for hyaluronate Cell 1990 61 7 1303 1313 1694723
  14. [16]Coradini D Pellizzaro C Miglierini G Daidone MG Perbellini A Hyaluronic acid as drug delivery for sodium butyrate: improvement of the anti-proliferative activity on a breast-cancer cell line Int J Cancer 1999 81 3 411 416 10209956
  15. [17]Luo Y Prestwich GD Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate Bioconjug Chem 1999 10 5 755 763 10502340
  16. [18]Auzenne E Ghosh SC Khodadadian M Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts Neoplasia 2007 9 6 479 486 17603630 PMC1899257
  17. [19]Akima K Ito H Iwata Y Evaluation of antitumor activities of hyaluronate binding antitumor drugs: synthesis, characterization and antitumor activity J Drug Target 1996 4 1 1 8 8798873
  18. [20]Eliaz RE Szoka FC Jr Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells Cancer Res 2001 61 6 2592 2601 11289136
  19. [21]Lee H Mok H Lee S Oh YK Park TG Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels J Control Release 2007 119 2 245 252 17408798
  20. [22]Papahadjopoulos D Allen TM Gabizon A Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy Proc Natl Acad Sci U S A 1991 88 24 11460 11464 1763060 PMC53155
  21. [23]Bae YH Park K Targeted drug delivery to tumors: myths, reality and possibility J Control Release 2011 153 3 198 205 21663778 PMC3272876
  22. [24]Li SD Huang L Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting J Control Release 2010 145 3 178 181 20338200 PMC2902652
  23. [25]Peer D Margalit R Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal Doxorubicin in syngeneic and human xenograft mouse tumor models Neoplasia 2004 6 4 343 353 15256056 PMC1502115
  24. [26]Carmichael J Possinger K Phillip P Advanced breast cancer: a phase II trial with gemcitabine J Clin Oncol 1995 13 11 2731 2736 7595731
  25. [27]Mini E Nobili S Caciagli B Landini I Mazzei T Cellular pharmacology of gemcitabine Ann Oncol 2006 17 Suppl 5 v7 v12 16807468
  26. [28]Pitts JD Cancer gene therapy: a bystander effect using the gap junctional pathway Mol Carcinog 1994 11 3 127 130 7945800
  27. [29]Cottin S Ghani K de Campos-Lima PO Caruso M Gemcitabine intercellular diffusion mediated by gap junctions: new implications for cancer therapy Mol Cancer 2010 9 141 20537146 PMC2898703
  28. [30]Grunewald R Abbruzzese JL Tarassoff P Plunkett W Saturation of 2′,2′-difluorodeoxycytidine 5′-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine Cancer Chemother Pharmacol 1991 27 4 258 262 1998982
  29. [32]Torchilin VP Recent advances with liposomes as pharmaceutical carriers Nat Rev Drug Discov 2005 4 2 145 160 15688077
  30. [34]Cosco D Bulotta A Ventura M In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer Cancer Chemother Pharmacol 2009 64 5 1009 1020 19263052
  31. [35]Celia C Malara N Terracciano R Liposomal delivery improves the growth-inhibitory and apoptotic activity of low doses of gemcitabine in multiple myeloma cancer cells Nanomedicine 2008 4 2 155 166 18430611
  32. [36]Celia C Calvagno MG Paolino D Improved in vitro anti-tumoral activity, intracellular uptake and apoptotic induction of gemcitabine-loaded pegylated unilamellar liposomes J Nanosci Nanotechnol 2008 8 4 2102 2113 18572621
  33. [37]Zhang L Yao HJ Yu Y Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cells Biomaterials 2012 33 2 565 582 21983136
  34. [38]Ma X Zhou J Zhang CX Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes Biomaterials 2013 34 18 4452 4465 23518403
  35. [39]Ponti D Costa A Zaffaroni N Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties Cancer Res 2005 65 13 5506 5511 15994920
  36. [40]Mayer LD Hope MJ Cullis PR Janoff AS Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles Biochim Biophys Acta 1985 817 1 193 196 4005257
  37. [41]Peer D Margalit R Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models Int J Cancer 2004 108 5 780 789 14696107
  38. [43]Bartlett GR Phosphorus assay in column chromatography J Biol Chem 1959 234 3 466 468 13641241
  39. [44]Di Ferrante N Turbidimetric measurement of acid mucopolysaccharides and hyaluronidase activity J Biol Chem 1956 220 1 303 306 13319348
  40. [46]Franken NA Rodermond HM Stap J Haveman J van Bree C Clonogenic assay of cells in vitro Nat Protoc 2006 1 5 2315 2319 17406473
  41. [47]Rodriguez LG Wu X Guan JL Wound-healing assay Methods Mol Biol 2005 294 23 29 15576902
  42. [48]Kim CE Lim SK Kim JS In vivo antitumor effect of cromolyn in PEGylated liposomes for pancreatic cancer J Control Release 2012 157 2 190 195 21963773
  43. [49]Shin DH Xuan S Kim WY Bae GU Kim JS CD133 antibody-conjugated immunoliposomes encapsulating gemcitabine for targeting glioblastoma stem cells J Mater Chem B 2014 2 24 3707 3898 32261723
  44. [50]Varricchio L Migliaccio A Castoria G Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor alpha tyrosine-phosphorylated peptide Mol Cancer Res 2007 5 11 1213 1221 18025264
  45. [51]Yun BL Cho N Li M Intratumoral heterogeneity of breast cancer xenograft models: texture analysis of diffusion-weighted MR imaging Korean J Radiol 2014 15 5 591 604 25246820 PMC4170160
  46. [52]Fillmore C Kuperwasser C Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man? Breast Cancer Res 2007 9 3 303 17540049 PMC1929090
  47. [53]Jones J Takeda A Tan SC Cooper K Loveman E Clegg A Gemcitabine for the treatment of metastatic breast cancer Health Technol Assess 2009 13 Suppl 2 1 7 19804683
  48. [54]Matsumura Y Maeda H A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res 1986 46 12 Pt 1 6387 6392 2946403
  49. [55]Maruyama K Yuda T Okamoto A Kojima S Suginaka A Iwatsuru M Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol) Biochim Biophys Acta 1992 1128 1 44 49 1390877
  50. [56]Liu D Mori A Huang L Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes Biochim Biophys Acta 1992 1104 1 95 101 1550858
  51. [57]Lian T Ho RJ Trends and developments in liposome drug delivery systems J Pharm Sci 2001 90 6 667 680 11357170
  52. [58]Liu H Patel MR Prescher JA Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models Proc Natl Acad Sci U S A 2010 107 42 18115 18120 20921380 PMC2964232
  53. [59]Tang J Zhang L She X Inhibiting CD164 expression in colon cancer cell line HCT116 leads to reduced cancer cell proliferation, mobility, and metastasis in vitro and in vivo Cancer Invest 2012 30 5 380 389 22409183
  54. [60]Guo S Xiao D Liu H Zheng X Liu L Liu S Interfering with CXCR4 expression inhibits proliferation, adhesion and migration of breast cancer MDA-MB-231 cells Oncol Lett 2014 8 4 1557 1562 25202367 PMC4156168

Cited by

Sorted by citations

See all 65

Metadata

Authors
Han, Shin, D. H., Kim, J. S., Weon, K. Y., Jang, C.-Y., & Kim, J.-S.
Venue
International Journal of Nanomedicine
Publisher
Informa UK Limited
Published
2016-04
Pages
1413
ISSN
1178-2013
DOI
10.2147/ijn.s95850
PMC
PMC4827594
Cited by
65
References
3
Language
en
Licence
creativecommons.org/licenses/by-nc/3.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review